Positron Emission Tomography Molecular Imaging of Dopaminergic System in Drug Addiction

被引:19
|
作者
Hou, Haifeng [2 ,3 ,4 ]
Tian, Mei [1 ]
Zhang, Hong [2 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Dept Nucl Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China
[3] Zhejiang Univ, Med PET Ctr, Hangzhou 310009, Zhejiang, Peoples R China
[4] Zhejiang Univ, Inst Nucl Med & Mol Imaging, Hangzhou 310009, Zhejiang, Peoples R China
来源
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY | 2012年 / 295卷 / 05期
基金
美国国家科学基金会;
关键词
positron emission tomography; dopamine; dopamine receptor; drug addiction; heroin; MU-OPIOID RECEPTOR; METHADONE-MAINTENANCE TREATMENT; C-11; BETA-CIT; NUCLEUS-ACCUMBENS; D2; RECEPTORS; BEHAVIORAL ADDICTIONS; CANNABINOID MECHANISM; TRANSPORTER DENSITY; COCAINE ADDICTION; PET EXAMINATION;
D O I
10.1002/ar.22457
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Dopamine (DA) is involved in drug reinforcement, but its role in drug addiction remains unclear. Positron emission tomography (PET) is the first technology used for the direct measurement of components of the dopaminergic system in the living human brain. In this article, we reviewed the major findings of PET imaging studies on the involvement of DA in drug addiction, especially in heroin addiction. Furthermore, we summarized PET radiotracers that have been used to study the role of DA in drug addiction. To investigate presynaptic function in drug addiction, PET tracers have been developed to measure DA synthesis and transport. For the investigation of postsynaptic function, several radioligands targeting dopamine one (D1) receptor and dopamine two (D2) receptor are extensively used in PET imaging studies. Moreover, we also summarized the PET imaging findings of heroin addiction studies, including heroin-induced DA increases and the reinforcement, role of DA in the long-term effects of heroin abuse, DA and vulnerability to heroin abuse and the treatment implications. PET imaging studies have corroborated the role of DA in drug addiction and increase our understanding the mechanism of drug addiction. Anat Rec, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:722 / 733
页数:12
相关论文
共 50 条
  • [31] Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism
    Yang, Yujie
    Li, Xinyi
    Lu, Jiaying
    Ge, Jingjie
    Chen, Mingjia
    Yao, Ruixin
    Tian, Mei
    Wang, Jian
    Liu, Fengtao
    Zuo, Chuantao
    NEURAL REGENERATION RESEARCH, 2025, 20 (01) : 93 - 106
  • [32] Recent progress in the applications of presynaptic dopaminergic positron emission tomography imaging in parkinsonism
    Yujie Yang
    Xinyi Li
    Jiaying Lu
    Jingjie Ge
    Mingjia Chen
    Ruixin Yao
    Mei Tian
    Jian Wang
    Fengtao Liu
    Chuantao Zuo
    Neural Regeneration Research, 2025, 20 (01) : 93 - 106
  • [33] Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
    Lamberts, Laetitia E.
    Williams, Simon P.
    van Scheltinga, Anton G. T. Terwisscha
    Lub-de Hooge, Marjolijn N.
    Schroeder, Carolien P.
    Gietema, Jourik A.
    Brouwers, Adrienne H.
    de Vries, Elisabeth G. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1491 - 1503
  • [34] Positron emission tomography imaging studies of dopamine receptors in primate models of addiction
    Nader, Michael A.
    Czoty, Paul W.
    Gould, Robert W.
    Riddick, Natallia V.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2008, 363 (1507) : 3223 - 3232
  • [35] Positron emission tomography imaging of the γ-aminobutyric acid system
    Andersson, Jan D.
    Matuskey, David
    Finnema, Sjoerd J.
    NEUROSCIENCE LETTERS, 2019, 691 : 35 - 43
  • [36] Positron emission tomography in substance abuse and addiction
    Schreckenberger, M.
    NERVENHEILKUNDE, 2009, 28 (10) : 727 - 732
  • [37] Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis
    Matthews, Paul M.
    Datta, Gourab
    EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (05) : 557 - 570
  • [38] Visualization with positron emission tomography, computed tomography, magnetic resonance imaging, positron emission tomography/computed tomography, and positron emission tomography/magnetic resonance imaging
    Seemann, MD
    Gaa, J
    CIRCULATION, 2005, 112 (21) : E329 - E330
  • [40] Molecular Imaging Using Positron Emission Tomography in Colorectal Cancer
    Lin, Michael
    DISCOVERY MEDICINE, 2011, 11 (60) : 435 - 447